All stock lists
BP p.l.c. (New York Stock Exchange:BP)
GB · Delayed Price · Currency is USD
Energy · Oil & Gas Integrated
50.35+0.56 (+1.12%)
Market cap
$132B
Insider Score
Health Score
Analyst consensus
Listed since
Jan 3, 1977
Website
Insider Score
––Not scored
BP Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
Financial Health Score
Sound
From BP’s reported statements · Q2 2026 (trailing 12 months)
Profitability11 / 20
Profitable, but on a thin margin.
- Revenue
- $218.17B
- Net income
- $5.49B
- Net margin
- 2.5%
Leverage16 / 20
Little or no net debt.
- Total debt
- $72.69B
- Cash
- $37.17B
- Net debt / EBITDA
- 0.89x
Liquidity10 / 20
Covers near-term obligations, without much room.
- Current assets
- $121.29B
- Current liabilities
- $95.36B
- Current ratio
- 1.27
Cash generation16 / 20
The business funds itself from operations.
- Operating cash flow
- $29.11B
- Free cash flow
- $16.14B
- FCF margin
- 7.4%
Dilution & runway20 / 20
Not funding itself by issuing shares.
- Shares outstanding
- 2587.0M
- Share growth (1y)
- -0.8%
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
BP Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 70.11 B | 52.26 B | 47.38 B | 48.42 B | 46.63 B | 46.91 B |
| Revenue Growth (YoY) | 50.37 % | 11.41 % | 3.56 % | 2.47 % | -1.42 % | -4.04 % |
| Cost of Revenue | 50.73 B | 39.63 B | 39.70 B | 39.55 B | 38.08 B | 38.46 B |
| Gross Profit | 19.38 B | 12.63 B | 7.68 B | 8.87 B | 8.54 B | 8.44 B |
| SG&A Expense | 4.61 B | 4.63 B | 4.57 B | 4.27 B | 4.24 B | 4.41 B |
| R&D Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 10.44 B | 4.67 B | 4.67 B | 4.50 B | 4.38 B | 4.51 B |
| Operating Income | 8.94 B | 7.96 B | 3.00 B | 4.37 B | 4.16 B | 3.93 B |
| Pretax Income | 7.82 B | 7.37 B | -1.50 B | 3.24 B | 2.88 B | 3.13 B |
| Tax Provision | 3.49 B | 3.15 B | 1.62 B | 1.73 B | 954.00 M | 2.15 B |
| Net Income | 3.91 B | 3.84 B | -3.42 B | 1.16 B | 1.63 B | 687.00 M |
| EPS (Basic) | 1.50 | 1.50 | -1.32 | 0.45 | 0.62 | 0.26 |
| EPS (Diluted) | 1.44 | 1.44 | -1.32 | 0.44 | 0.62 | 0.26 |
| Shares Outstanding | 2.59 B | 2.58 B | 2.57 B | 2.59 B | 2.61 B | 2.63 B |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.